Leukemia &a; Lymphoma Society
Leukemia &a; Lymphoma Society, a voluntary health organization, funds research, finds cures, and offers treatments for blood cancer patients.
Business Model:
Revenue: $9.3M
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Leukemia &a; Lymphoma Society Information
Geographic Data
Address: 1311 Mamaroneck Ave
City: White Plains
State: NY
Zip: 10605
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
182,144Website Global Rank
406,117Website Monthly Traffic
Twitter Followers
Description
Leukemia & Lymphoma Society provides treatment for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative diseases.
Contact Phone:
+19149495213
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2011 | Epizyme | Venture Round | 0 |
| 8/2021 | Immunitas Therapeutics | Series B | 0 |
| 6/2022 | ImCheck Therapeutics | Series C | 0 |
| 8/2019 | University of Arkansas for Medical Sciences | Grant | 0 |
| 8/2014 | OncoPep | Series B | 6.9M |
| 3/2021 | Caribou Biosciences | Series C | 115M |
| 8/2019 | Forty Seven | Post-IPO Equity | 0 |
| 3/2020 | Kymera Therapeutics | Corporate Round | - |
| 3/2021 | Immune-Onc Therapeutics | Series B | 0 |
| 6/2022 | ImCheck Therapeutics | Series C | 0 |
| 8/2021 | Immunitas Therapeutics | Series B | 0 |
| 3/2021 | Immune-Onc Therapeutics | Series B | 0 |
| 3/2021 | Caribou Biosciences | Series C | 0 |
| 3/2020 | Kymera Therapeutics | Corporate Round | - |
| 8/2019 | University of Arkansas for Medical Sciences | Grant | 0 |
| 8/2019 | Forty Seven | Post-IPO Equity | 0 |
| 8/2014 | OncoPep | Series B | 0 |
| 6/2011 | Epizyme | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
